ReWalk Robotics Ltd. (RWLK)

1.3500 +0.1000 (+8.00%) At close: 4:00PM EDT

ReWalk Robotics Ltd.

3 Hatnufa Street
6th Floor PO Box 161
Yokneam Illit 2069203
Israel
972 4 959 0123
http://www.rewalk.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 49

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Lawrence J. Jasinski	CEO & Director	555.79k	N/A	1957
Mr. Ori Gon	Chief Financial Officer	303.42k	N/A	1982
Ms. Miri Pariente	VP of Operations, Regulatory & Quality	N/A	N/A	1977
Ms. Judy Kula	VP of Customer Service, HR & Bus. Affairs	N/A	N/A	N/A
Mr. Ami Kraft	Exec. Advisor to the CEO	N/A	N/A	1943

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.

Corporate governance

ReWalk Robotics Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.